AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
-
- Amit G. Singal
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
-
- Josep M. Llovet
- Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, New York, USA
-
- Mark Yarchoan
- Department of Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA
-
- Neil Mehta
- University of California, San Francisco, San Francisco, California, USA
-
- Julie K. Heimbach
- Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota, USA
-
- Laura A. Dawson
- Radiation Medicine Program/University Health Network, Department of Radiation Oncology, University of Toronto, Toronto, Canada
-
- Janice H. Jou
- Division of Gastroenterology and Hepatology, Oregon Health and Science University, Portland, Oregon, USA
-
- Laura M. Kulik
- Northwestern Medical Faculty Foundation, Chicago, Illinois, USA
-
- Vatche G. Agopian
- The Dumont–University of California, Los Angeles, Transplant Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
-
- Jorge A. Marrero
- Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
-
- Mishal Mendiratta-Lala
- Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan, USA
-
- Daniel B. Brown
- Department of Radiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
-
- William S. Rilling
- Division of Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
-
- Lipika Goyal
- Department of Medicine, Stanford School of Medicine, Palo Alto, California, USA
-
- Alice C. Wei
- Memorial Sloan Kettering Cancer Center, New York City, New York, USA
-
- Tamar H. Taddei
- Department of Medicine (Digestive Diseases), Yale School of Medicine, New Haven, CT, USA
収録刊行物
-
- Hepatology
-
Hepatology 2023-05-22
Ovid Technologies (Wolters Kluwer Health)